Zevra Therapeutics Inc (ZVRA)
6.92
-0.39
(-5.34%)
USD |
NASDAQ |
Sep 27, 16:00
6.92
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Gross Profit (Quarterly): 0.876M for June 30, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.876M |
March 31, 2024 | 3.25M |
December 31, 2023 | 11.22M |
September 30, 2023 | 2.751M |
June 30, 2023 | 7.793M |
March 31, 2023 | 3.051M |
December 31, 2022 | 2.00M |
September 30, 2022 | 2.733M |
June 30, 2022 | 1.249M |
March 31, 2022 | 3.957M |
December 31, 2021 | 2.523M |
September 30, 2021 | 1.965M |
Date | Value |
---|---|
June 30, 2021 | 10.99M |
March 31, 2021 | 11.12M |
December 31, 2020 | 2.366M |
September 30, 2020 | 1.925M |
June 30, 2020 | 6.266M |
March 31, 2020 | 1.426M |
December 31, 2019 | -0.569M |
September 30, 2019 | 10.46M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.569M
Minimum
Dec 2019
11.22M
Maximum
Dec 2023
4.367M
Average
2.742M
Median
Gross Profit (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 47.74M |
BioCardia Inc | -- |
Verrica Pharmaceuticals Inc | 4.635M |
Xeris Biopharma Holdings Inc | 40.28M |
Crinetics Pharmaceuticals Inc | -- |